Vorinostat (Unravel Biosciences)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameVorinostat (Unravel Biosciences)
Drug Alias NameRVL-001
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsPitt-Hopkins syndromeWolf-Hirschhorn SyndromeRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesColombia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUnravel Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnravel Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPitt-Hopkins syndromeWolf-Hirschhorn SyndromeRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A